|
1
|
Ganem D and Prince AM: Hepatitis B virus
infection-natural history and clinical consequences. New Engl J
Med. 350:1118–1129. 2004. View Article : Google Scholar
|
|
2
|
Hernandez-Gea V and Friedman SL:
Pathogenesis of liver fibrosis. Annu Rev Pathol. 6:425–456. 2011.
View Article : Google Scholar
|
|
3
|
Friedman SL: Evolving challenges in
hepatic fibrosis. Nat Rev Gastroenterol Hepatol. 7:425–436. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang FS and Zhang Z: Host immunity
influences disease progression and antiviral efficacy in humans
infected with hepatitis B virus. Expert Rev Gastroenterol Hepatol.
3:499–512. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dancygier H and Schirmacher P: Immune
mediated liver injury. Clinical Hepatology. Dancygier H: Springer;
Berlin, Germany: pp. 191–196. 2010
|
|
6
|
Jung MC and Pape GR: Immunology of
hepatitis B infection. Lancet Infect Dis. 2:43–50. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang FS: Clinical immune characterization
of hepatitis B virus infection and implications for immune
intervention: Progress and challenges. Hepatol Res. 37(Suppl 3):
S339–S346. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Harrington LE, Hatton RD, Mangan PR,
Turner H, Murphy KM and Weaver CT: Interleukin 17-producing CD4+
effector T cells develop via a lineage distinct from the T helper
type 1 and 2 lineages. Nat Immunol. 6:1123–1132. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shi M, Wei J, Dong J, Meng W, Ma J, Wang
T, Wang N and Wang Y: Function of interleukin-17 and -35 in the
blood of patients with hepatitis B-related liver cirrhosis. Mol Med
Rep. 11:121–126. 2015.
|
|
10
|
Jaeschke H and Hasegawa T: Role of
neutrophils in acute inflammatory liver injury. Liver Int.
26:912–919. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang JY, Zhang Z, Lin F, Zou ZS, Xu RN,
Jin L, Fu JL, Shi F, Shi M, Wang HF and Wang FS:
Interleukin-17-producing CD4(+) T cells increase with severity of
liver damage in patients with chronic hepatitis B. Hepatology.
51:81–91. 2010. View Article : Google Scholar
|
|
12
|
Zhang Z, Zou ZS, Fu JL, Cai L, Jin L, Liu
YJ and Wang FS: Severe dendritic cell perturbation is actively
involved in the pathogenesis of acute-on-chronic hepatitis B liver
failure. J Hepatol. 49:396–406. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Szabo G, Mandrekar P and Dolganiuc A:
Innate immune response and hepatic inflammation. Semin Liver Dis.
27:339–350. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ge J, Wang K, Meng QH, Qi ZX, Meng FL and
Fan YC: Implication of Th17 and Th1 cells in patients with chronic
active hepatitis B. J Clin Immunol. 30:60–67. 2010. View Article : Google Scholar
|
|
15
|
Zhao RR, Yang XF, Dong J, Zhao YY, Wei X,
Huang CX, Lian JQ and Zhang Y: Toll-like receptor 2 promotes T
helper 17 cells response in hepatitis B virus infection. Int J Clin
Exp Med. 8:7315–7323. 2015.PubMed/NCBI
|
|
16
|
Li X, Liu X, Tian L and Chen Y:
Cytokine-mediated immuno-pathogenesis of hepatitis B virus
infections. Clin Rev Allergy Immunol. 1–14, epub. 2014.
|
|
17
|
Kondo Y, Ueno Y and Shimosegawa T:
Immunopathogenesis of hepatitis B persistent infection:
Implications for immunothera-peutic strategies. Clin J
Gastroenterol. 2:71–79. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kondo Y, Ueno Y, Kobayashi K, Kakazu E,
Shiina M, Inoue J, Tamai K, Wakui Y, Tanaka Y, Ninomiya M, et al:
Hepatitis B virus replication could enhance regulatory T cell
activity by producing soluble heat shock protein 60 from
hepatocytes. J Infect Dis. 202:202–213. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yuan Q, Hong S, Shi B, Kers J, Li Z, Pei
X, Xu L, Wei X and Cai M: CD4(+)CD25(-)Nrp1(+) T cells synergize
with rapamycin to prevent murine cardiac allorejection in
immunocompetent recipients. PLoS One. 8:e611512013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Voelkl S, Gary R and Mackensen A:
Characterization of the immunoregulatory function of human TCR-αβ+
CD4- CD8-double-negative T cells. Eur J Immunol. 41:739–748. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang BL, Su H, Chen Y, Wang J and Xu GL: A
role for tricho-santhin in the expansion of CD4CD25 regulatory T
cells. Scand J Immunol. 71:258–266. 2015. View Article : Google Scholar
|
|
22
|
Lambotin M, Raghuraman S, Stoll-Keller F,
Baumert TF and Barth H: A look behind closed doors: Interaction of
persistent viruses with dendritic cells. Nat Rev Microbiol.
8:350–360. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xie Q, Shen HC, Jia NN, Wang H, Lin LY, An
BY, Gui HL, Guo SM, Cai W, Yu H, et al: Patients with chronic
hepatitis B infection display deficiency of plasmacytoid dendritic
cells with reduced expression of TLR9. Microbes Infect. 11:515–523.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Carotenuto P, Artsen A, Niesters HG,
Osterhaus AD and Pontesilli O: In vitro use of autologous dendritic
cells improves detection of T cell responses to hepatitis B virus
(HBV) antigens. J Med Virol. 81:332–339. 2009. View Article : Google Scholar
|
|
25
|
Sakaguchi S, Yamaguchi T, Nomura T and Ono
M: Regulatory T cells and immune tolerance. Cell. 133:775–787.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Thimme R, Wieland S, Steiger C, Ghrayeb J,
Reimann KA, Purcell RH and Chisari FV: CD8(+) T cells mediate viral
clearance and disease pathogenesis during acute hepatitis B virus
infection. J Virol. 77:68–76. 2003. View Article : Google Scholar :
|
|
27
|
Pawlotsky JM: EASL Clinical Practice
Guidelines. J Hepatol. 50:2432009. View Article : Google Scholar
|
|
28
|
Bettelli E, Korn T, Oukka M and Kuchroo
VK: Induction and effector functions of T(H)17 cells. Nature.
453:1051–1057. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhou L, Lopes JE, Chong MM, Ivanov II, Min
R, Victora GD, Shen Y, Du J, Rubtsov YP, Rudensky AY, et al:
TGF-β-induced Foxp3 inhibits T(H)17 cell differentiation by
antagonizing RORgammat function. Nature. 453:236–240. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bettelli E, Carrier Y, Gao W, Korn T,
Strom TB, Oukka M, Weiner HL and Kuchroo VK: Reciprocal
developmental pathways for the generation of pathogenic effector
TH17 and regulatory T cells. Nature. 441:235–238. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Veldhoen M, Hocking RJ, Atkins CJ,
Locksley RM and Stockinger B: TGFbeta in the context of an
inflammatory cytokine milieu supports de novo differentiation of
IL-17-producing T cells. Immunity. 24:179–189. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ando DG, Clayton J, Kono D, Urban JL and
Sercarz EE: Encephalitogenic T cells in the B10. PL model of
experimental allergic encephalomyelitis (EAE) are of the Th-1
lymphokine subtype. Cell Immunol. 124:132–143. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Park H, Li Z, Yang XO, Chang SH, Nurieva
R, Wang YH, Wang Y, Hood L, Zhu Z, Tian Q and Dong C: A distinct
lineage of CD4 T cells regulates tissue inflammation by producing
interleukin 17. Nat Immunol. 6:1133–1141. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Bouchliou I, Miltiades P, Nakou E,
Spanoudakis E, Goutzouvelidis A, Vakalopoulou S, Garypidou V,
Kotoula V, Bourikas G, Tsatalas C and Kotsianidis I: Th17 and
Foxp3(+) T regulatory cell dynamics and distribution in
myelodysplastic syndromes. Clin Immunol. 139:350–359. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Maek-A-Nantawat W, Buranapraditkun S,
Klaewsongkram J and Ruxrungthum K: Increased interleukin-17
production both in helper T cell subset Th17 and CD4-negative T
cells in human immunodeficiency virus infection. Viral Immunol.
20:66–75. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Acosta-Rodriguez EV, Rivino L, Geginat J,
Jarrossay D, Gattorno M, Lanzavecchia A, Sallusto F and Napolitani
G: Surface phenotype and antigenic specificity of human interleukin
17-producing T helper memory cells. Nat Immunol. 8:639–646. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Harrington LE, Hatton RD, Mangan PR,
Turner H, Murphy TL, Murphy KM and Weaver CT: Interleukin
17-producing CD4+ effector T cells develop via a lineage distinct
from the T helper type 1 and 2 lineages. Nat Immunol. 6:1123–1132.
2005. View
Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lemmers A, Moreno C, Gustot T, Maréchal R,
Degré D, Demetter P, de Nadai P, Geerts A, Quertinmont E,
Vercruysse V, et al: The interleukin-17 pathway is involved in
human alcoholic liver disease. Hepatology. 49:646–657. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Harada K, Shimoda S, Sato Y, Isse K, Ikeda
H and Nakanuma Y: Periductal interleukin-17 production in
association with biliary innate immunity contributes to the
pathogenesis of cholangiopathy in primary biliary cirrhosis. Clin
Exp Immunol. 157:261–270. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wang R, Kozhaya L, Mercer F, Khaitan A,
Fujii H and Unutmaz D: Expression of GARP selectively identifies
activated human FOXP3+ regulatory T cells. Proc Natl Acad Sci U S
A. 106:13439–13444. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Peng G, Li S, Wu W, Sun Z, Chen Y and Chen
Z: Circulating CD4+ CD25+ regulatory T cells correlate with chronic
hepatitis B infection. Immunology. 123:57–65. 2008. View Article : Google Scholar
|
|
42
|
Niu Y, Liu H, Yin D, Yi R, Chen T, Xue H,
Zhang S, Lin S and Zhao Y: The balance between intrahepatic
IL-17(+) T cells and Foxp3(+) regulatory T cells plays an important
role in HBV-related end-stage liver disease. BMC Immunol.
12:472011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zhang JY, Song CH, Shi F, Zhang Z, Fu JL
and Wang FS: Decreased ratio of Treg cells to Th17 cells correlates
with HBV DNA suppression in chronic hepatitis B patients undergoing
entecavir treatment. PLoS One. 5:e138692010. View Article : Google Scholar : PubMed/NCBI
|
